Navigation Links
Three Arrested For Illegal Export Of Ephedrine Tablets

The Directorate of Revenue Intelligence arrested three persons, including the Managing Director of a pharmaceutical company based at Vijayawada//, for alleged illegal export of Ephedrine tablets, a controlled substance notified under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985.

According to Directorate of Revenue Intelligence here today, the arrested persons have been remanded to judicial custody by the Metropolitan Sessions Judge, Hyderabad.

The arrested persons had ‘conspired in procurement and illegal export of around 2500 cartons each containing one lakh tablets valued at Rs 10 crore in the international market’, the release said.

The examination of the Laptop maintained by the Managing Director of Venkat Pharma Limited, having its factory at Vijayawada and registered office at Hyderabad, revealed that they have ‘exported the Ephedrine tables in the guise of their regular pharmaceutical formulations’.

The Managing Director procured the said tablets from local dealers through another accused based at Vijayawada.

The former business development head of the pharmaceutical company was also arrested who had visited some Africian countries and liaised with customers for distribution of these tablets, the release added.

Source: PTI Nes
'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Nobel Prize for Medicine shared by Three scientists
3. Three Tropical Parasites Genetic Code Unravelled
4. The Future Pattern Of Weight Gain Is Laid As Early As Three Years Of Age
5. Smoking Increases The Risk Of Heart Disease By Three Times
6. Three Sisters Have One Baby and Make History
7. Three In One Ultrasound Probe For 3-D Imaging Of Heart And Tissue Destruction Developed
8. Three More Bird Flu Cases Reported By China
9. Three meals daily Keeps Keralas elderly Healthy
10. Three dimensional structure of apolipoprotein revealed
11. Delhi Witnessed 34 Meningitis Deaths In Three Months
Post Your Comments:
Other Medicine Technology:Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 2Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 3Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 2Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 3Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 4Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 5Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 6Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 7Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 8Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 9Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 10